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Abstract: Brain-related experiments are limited by nature, and so biological insights are often limited
or absent. This is particularly problematic in the context of brain cancers, which have very poor
survival rates. To generate and test new biological hypotheses, researchers have started using
mathematical models that can simulate tumour evolution. However, most of these models focus on
single-scale 2D cell dynamics, and cannot capture the complex multi-scale tumour invasion patterns
in 3D brains. A particular role in these invasion patterns is likely played by the distribution of micro-
fibres. To investigate the explicit role of brain micro-fibres in 3D invading tumours, in this study, we
extended a previously introduced 2D multi-scale moving-boundary framework to take into account
3D multi-scale tumour dynamics. T1 weighted and DTI scans are used as initial conditions for our
model, and to parametrise the diffusion tensor. Numerical results show that including an anisotropic
diffusion term may lead in some cases (for specific micro-fibre distributions) to significant changes in
tumour morphology, while in other cases, it has no effect. This may be caused by the underlying
brain structure and its microscopic fibre representation, which seems to influence cancer-invasion
patterns through the underlying cell-adhesion process that overshadows the diffusion process.
Keywords: cancer invasion; cell adhesion; multi-scale modelling; 3D computational modelling; T1
weighted image; DTI; glioblastoma
1. Introduction
Glioblastoma multiforme is a highly invasive and aggressive type of brain tumour,
typically with poor patient prognosis [1–7] (with a median survival rate of less than one
year [8]). These tumours arise from abnormal glial cells located in the central nervous
system, and shortly after their appearance, they invade the surrounding tissues in a
heterogeneous fashion. This heterogeneous invasion pattern leads to tumours whose outer
edges are difficult or impossible to determine with current imaging technologies, including
for instance magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI), both of
which measure the diffusion of water molecules and enable the study of brain structures.
Due to the limited experimental approaches that one can use to study the brain,
researchers have started using mathematical models to provide certain biological insights
that otherwise would be difficult to obtain experimentally. Such models can help predict
how tumours grow for specific patients, aiding clinicians in decision-making, or they
can help test and provide new hypotheses about potential anti-tumour treatments. The
mathematical modelling of tumours has seen significant advances in recent decades, which
have broadened our understanding of tumour dynamics and how cells interact with their
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environment [9–33]. Although the majority of these models do not restrict themselves to a
specific tumour type and rather focus on general tumours, there are some models that focus
on the evolution of gliomas within the brain [34–42]. Recently, models have also started to
incorporate the structure of the brain, by including MRI and DTI scans [35–37,43–46]. Even
though these images are generated in 3D, most of these models are simulating tumour
growth in 2D and only a few of them are 3D models [43,47,48]. Moreover, the majority of
published models have focused on tumour progression only on one spatio-temporal scale.
However, tumour progression is characterised by various biological processes occurring on
different scales, and thus their effects on the overall tumour dynamics cannot be neglected.
Hence, recent efforts have been made to establish new multi-scale frameworks for tumour
progression [26–30,35–37,49], which were able to capture some of these underlying multi-
scale biological processes usually involving the extracellular matrix (ECM).
In this paper, we extended the general 2D multi-scale moving-boundary modelling
framework introduced in [20,26] to capture the invasion of glioblastomas within a 3D
fibrous brain environment. To this end, we incorporated the information provided by
both the T1 weighted and DTI scans into our multi-scale framework and used the re-
sulting model to numerically simulate the growth of 3D gliomas within the brain. We
focused on a few cases showing tumour growth in different regions in the brain, with
different distributions of grey/white matter densities, which leads to different tumour
invasion patterns.
The model presented in this paper is a first to advance the multi-scale moving bound-
ary modelling of 3D brain gliomas in two key ways compared to previous ones, as can be
seen for instance in [35–37]. On the one hand, using this modelling framework, we explic-
itly address the micro-fibres and their rearrangement dynamics caused by the macro-scale
movement of the cancer cell population (a process of great importance as the micro-scale
structural changes of the underlying tissue can significantly influence the cell popula-
tion motility). On the other hand, we also model another vital proteolytic process that
occurs along the invasive edge of the tumour, allowing us to explicitly model tumour
morphological changes and how the tumour boundary progresses over a time interval.
This paper is organised as follows. First, we formulate our extended multi-scale moving
boundary framework in Section 2. Then, following a brief description of the numerical
methods, we present the computational simulation results in Section 3. Finally, in Section 4,
we summarise and discuss these results.
2. Multi-Scale Modelling of the Tumour Dynamics
To model the evolution of glioblastomas within a three-dimensional brain, we employ
a multi-scale moving boundary model that was initially introduced in [20] and later
expanded in several other works [26–30,49]. To account for the brain’s structure, we aim to
use 3D T1 weighted and DTI scans that ultimately influence the migration of the cancer
cells as well as affect both micro-scale dynamics. Hence, here we aim to explore the impact
of the brain structure on the interlinked macro-scale and micro-scale tumour dynamics.
2.1. Macro-Scale Dynamics
Since in this work we extend the 2-dimensional (2D) modelling framework introduced
in [20,26], we begin by briefly describing some of the key features of this framework and
by giving a few useful notations. First, we denote by Ω(t) the expanding 3-dimensional
(3D) tumour region that progresses over the time interval [0, T] within a maximal tissue
cube Y ⊂ RN with N = 3, i.e., Ω(t) ⊂ Y, ∀t ∈ [0, T]; as can also be seen in Figure 1.
















Figure 1. Schematics of the multi-scale model: (a) Illustration of the sensing region B(x, R), the
two vectors y and y + θ f (y + x, t) and the overall travelling direction Ac; (b) an example of a fibre
micro-domain δY(x) containing fibres (blue lines) that induces an overall orientation θ f (x, t) for
δY(x); (c) an example of a boundary micro-domain εY(x) where the blue volume represents the
tumour volume at the current time-step with boundary point x and the red volume represents the
evolved tumour at the next time-step with shifted boundary point x∗εY .
Then, at any macro-scale spatio-temporal point (x, t) ∈ Y × [0, T], we consider a
cancer cell population c(x, t) that is placed within and interacts with a two-phase ECM:
the non-fibre l(x, t) and fibre F(x, t) ECM phases [26–30]. On the one hand, the fibre ECM
phase accounts for all major fibrous proteins such as collagen and fibronectin, whose
micro-scale distribution induces the spatial orientation of ECM fibres. Hence, the macro-
scale spatio-temporal distribution of the ECM fibres is represented by an oriented vector
field θ f (x, t) that describes their spatial bias, as well as by F(x, t) :=‖ θ f (x, t) ‖, which
denotes the amount of fibres at a macro-scale point (x, t) [26–30]. On the other hand, in the
non-fibre ECM phase, we bundle together every other ECM constituent such as non-fibrous
proteins (for example amyloid fibrils), enzymes, polysaccharides and extracellular Ca2+
ions [26–30]. Furthermore, in this new modelling study, we incorporate the structure of the
brain by extracting data from DTI and T1 weighted brain scans, and then use these data to
parametrise the model. Specifically, we denote by DWater(x) the water diffusion tensor that
is induced by the DTI scan. Furthermore, we denote by w(x) the white matter density and
by g(x) the grey matter density, both of which are extracted from the T1 weighted image.
Finally, to facilitate the description of the model and to make the mathematical notations
more compact, we denote by u the global tumour vector which at each (x, t) is given by
u := (c(x, t), l(x, t), F(x, t))ᵀ.
With this notation, the total space occupied by the macroscopic tissue is denoted by
ρ(u) and is defined as
ρ(u) = ρ(c(x, t), l(x, t), F(x, t)) := c(x, t) + l(x, t) + F(x, t).
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2.1.1. Cancer Cell Population Dynamics
To describe the spatio-temporal evolution of the cancer cell population c(x, t), we first
assume a logistic-type growth with rate µ [26–30,50–52]. For the movement of this cell
population, we use the structure of the brain by taking into account both the T1 weighted
and DTI scans (from the IXI Dataset [53]), as well as the various adhesion-mediated






































, N = 3,
with Di,j denoting the components of the tumour diffusion tensor DT . Since classical
diffusion models with a constant coefficient cannot capture any directional cues, as those
provided by the DTI data, in Equation (1), we use a tensor model (involving a fully
anisotropic diffusion term) that is able to incorporate the anisotropic nature of the cancer
cell movement. These tensor models were proposed in [60–63] and have been used to
mathematically model the gliomas within the brain; see for instance [35–37]. The main idea
of this approach is to use the measured water diffusivity in the structured, fibrous brain
environment characterised by a symmetric water diffusion tensor [64]:
DWater(x) =
dxx(x) dxy(x) dxz(x)dxy(x) dyy(x) dyz(x)
dxz(x) dyz(x) dzz(x)
, (2)
and appropriately construct a macroscopic diffusion tensor for the cancer cell population.
Since this water tensor (2) is naturally symmetric (due to the DTI scans) [64], it can be
diagonalised. Denoting its eigenvalues by λ1(x) ≥ · · · ≥ λN(x) and the associated eigen-
vectors by φ1(x), · · · φN(x), we follow [37,65,66] and construct the 3D tumour diffusion
tensor as
DT(x) := Dc DWG(x)
[(






















Here, Dc > 0 is the diffusion coefficient, r ∈ [0, 1] specifies the degree of isotropic
diffusion, I3 denotes the 3× 3 identity matrix, and k(x) is given by
k(x) := KFAFA(x),
with KFA ≥ 0 being a proportionality constant measuring the sensitivity of the cells to the
environments’ direction, and FA(x) denotes the fractional anisotropy index [67] given by
FA(x) :=
√
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Finally, it is well known that the malignant glioma cells positioned in the white matter
exercise quicker motility than those situated in the grey matter [39,68–70]. To account for
this effect, in (3), we use a regulator term DWG(·) that is given by
DWG(x) = a + (1− a)
((





where 0 ≤ DG ≤ 1 is the grey matter regulator coefficient, ∗ is the convolution operator [71],
ψρ := ψ(x)/ρN denotes the standard mollifier and g(x) and w(x) are the grey and white
matter densities provided by the T1 weighted image (following an image segmentation
process). Finally, 0 ≤ a ≤ 1 is a parameter that distinguishes between different cases (see
Section 3).
In addition, the movement of the cancer cells is further biased by various adhesion-
mediated process [54–59]. Due to the increasing evidence that gliomas induce a fibrous
environment within the brain [72–82], in (1), we model the overall adhesion process using
a non-local flux term that was introduced in [26] (see also [19,27–30,49,83,84] for similar
terms). Specifically, we explore the adhesive interactions of the cancer cells at x ∈ Ω(t) with
other neighbouring cancer cells, with the distribution of the non-fibre ECM phase [85–88]
as well as with the oriented fibre ECM phase [89,90], all located within a sensing region
B(x, R) of radius R > 0. For this, we define the non-local flux term as









Sccc(x + y, t) + Scl l(x + y, t)
)




where Scc, Scl , ScF > 0 are the strengths of the cell–cell, cell–non-fibre ECM and cell–fibre
ECM adhesions, respectively. While we take both Scl and ScF as positive constants, we con-
sider the emergence of strong and stable cell–cell adhesion bonds to be positively correlated
with the level of extracellular Ca+2 ions (one of the non-fibre ECM components) [91,92].
Hence, following the approach in [26–30], we describe the cell–cell adhesion strength by
Scc(x, t) := Smin + (Smax − Smin) exp
[
1− 1
1− (1− l(x, t))2
]
,
where Smin > 0 and Smax > 0 are the minimum and maximum levels of Ca+2 ions.
Furthermore, in (5), we denote by n(·) and n̂(·, ·) the unit radial vector and the unit radial





if y ∈ B(0, R) \ {0},
0 if y = 0,
n̂(y, θ f (x + y)) :=

y + θ f (x + y, t)
‖ y + θ f (x + y, t) ‖2
if y ∈ B(0, R) \ {0},
0 if y = 0,
respectively (for details on the fibre orientation θ f , see Section 2.2.1). Furthermore, to
account for the gradual weakening of all adhesion bonds as we move away from the
centre point x within the sensing region B(x, t) in (5), we use a radially symmetric kernel





, ∀y ∈ B(0, R),
where ψ(·) is the standard mollifier. Finally, in (5), a limiting term [1− ρ(u)]+ := max(0, 1−
ρ(u)) is used to prevent the contribution of overcrowded regions to cell migration [84]. For
a schematic of this adhesion process, we refer the reader to Figure 1a.
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2.1.2. Two-Phase ECM Macro-Scale Dynamics
In addition to the cancer cell population, the rest of the macro-scale tumour dynamics
are described by the two-phase ECM. Here, both fibre and non-fibre ECM phases are
assumed to be simply described by a degradation term due to the cancer cell population.








where βF > 0 and βl > 0 are the degradation rates of the fibre and non-fibre ECM phases,
respectively.
2.1.3. The Complete Macro-Dynamics
In summary, Equation (1) for cancer cells dynamics and Equation (6) for the two-phase
ECM dynamics lead to the following non-dimensional PDE system describing the evolution























To complete the macro-scale model description, we consider zero-flux boundary
conditions and appropriate initial conditions (for instance, the ones given in Section 3).
2.2. Micro-Scale Processes and the Double Feedback Loop
Since the cancer invasion process is genuinely a multi-scale phenomenon, several
micro-scale processes are closely linked to the macro-scale dynamics [93]. In this work,
we consider two of these micro-processes, namely the rearrangement of the ECM fibres
micro-constituents [26] and the cell-scale proteolytic processes that occur at the leading
edge of the tumour [20]. Here, we briefly outline these micro-processes, in addition to the
naturally arising double feedback loop that ultimately connects the micro-scale and the
macro-scale.
2.2.1. Two-Scale Representation and Dynamics of Fibres
To represent the oriented fibres on the macro-scale, we follow [26]. There, the authors
characterised not only the amount of fibres F(x, t) but also their ability to withstand
incoming cell fluxes and forces through their spatial bias. By considering a cell-scale micro-
domain δY(x) := x + δY of appropriate micro-scale size δ > 0, both of these characteristics
are induced by the microscopic fibre distribution f (z, t), with z ∈ δY(x). In fact, both of
these are captured though a vector field representation θ f (x, t) of the ECM micro-fibres [26]
that is defined as





f (z, t)dz ·
θ f ,δY(x)(x, t)
‖ θ f ,δY(x)(x, t) ‖2
, (8)
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where λ(·) is the Lebesgue measure in Rd and θ f ,δY(x)(·, ·) is the revolving barycentral
orientation given by [26]
θ f ,δY(x)(x, t) :=
∫
δY(x)




Hence, the fibres’ ability to withstand forces is naturally defined by this vector field
representation (8) and their amount distributed at a macro-scale point (x, t) is given by
F(x, t) :=‖ θ f (x, t) ‖2,
which is precisely the mean-value of the micro-fibres distributed on δY(x). Since both
of these macro-scale oriented ECM fibre characteristics (F(x, t) and θ f (x, t)) that we use
in the macro-scale dynamics (7), genuinely emerge from the micro-scale distribution of
the ECM fibres f (z, t), we refer to this link as the fibres bottom-up link. An illustration of a
micro-domain δY(x) and its corresponding macro-scale orientation θ f (x, t) can be seen in
Figure 1b.
On the other hand, there is also a naturally arising link that connects the macro-scale
to this micro-scale, namely the fibres top-down link. This connection is initiated by the
movement of the cancer cell population that triggers a rearrangement of ECM fibres micro-
constituents on each micro-domain δY(x) (enabled by the secretion of matrix-degrading
enzymes that can break down various ECM proteins). Hence, using the fact that the fully




= ∇ · [DT(x)∇c + c∇ ·
DT(x)], the fibre rearrangement process is kicked off by the cancer cell spatial flux:
Fc(x, t) := DT(x)∇c + c∇ ·DT(x)− cAc(x, t, u, θ f ), (9)
which is generated by the tumour macro-dynamics (7). Then, at any spatio-temporal point
(x, t) ∈ Ω(t)× [0, T] this flux (9) becomes naturally balanced in a weighted fashion by the
macro-scale ECM fibre orientation θ f (·, ·), resulting in a rearrangement flux [26]:
r(δY(x), t) := ω(x, t)Fc(x, t) + (1−ω(x, t))θ f (x, t), (10)
with ω(x, t) := c(x, t)/(c(x, t) + F(x, t)), that acts uniformly upon the micro-fibre distribu-
tion on each micro-domain δY(x). Ultimately, this macro-scale rearrangement vector (10)
induces a micro-scale reallocation vector νδY(x)(z, t) [26], enabling us to appropriately
calculate the new position z∗ of any micro-node z ∈ δY(x) as
z∗ := z + νδY(x)(z, t). (11)
For further details on the micro-fibre rearrangement process, we refer the reader to
Appendix B and [26–30].
2.2.2. MDE Micro-Dynamics and Its Links
The second micro-scale process that we take into consideration is the proteolytic
molecular process that occurs along the invasive edge of the tumour and is driven by
the cancer cells’ ability to secrete several types of matrix-degrading enzymes (MDEs) (for
instance, matrix-metalloproteinases) within the proliferating rim [94–98]. Subsequently to
the secretion, these MDEs are subject to spatial transport within a cell-scale neighbourhood
of the tumour interface and, as a consequence, they degrade the peritumoral ECM, resulting
in changes of tumour boundary morphology [93].
To explore such a micro-scale process, we adopt the approach that was first introduced
in [20] where the emerging spatio-temporal MDEs micro-dynamics is considered on an
appropriate cell-scale neighbourhood of the tumour boundary ∂Ω(t). This neighbour-
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hood is represented by a time-dependent bundle of overlapping cubic micro-domains
{εY}εY∈P(t), with ε > 0 being the size of each micro-domain εY, which allows us to decom-
pose the overall MDE micro-process, transpiring on
⋃
εY∈P(t) εY, into a union of proteolytic
micro-dynamics occurring on each εY; see also Figure 1c. Hence, choosing an arbitrary
micro-domain εY and a macroscopic time instance t0 ∈ [0, T], we follow the evolution of
the MDE micro-dynamics during the time period [t0, t0 + ∆t], with appropriately chosen
∆t > 0 and within the associated micro-domain εY. By denoting the spatio-temporal
distribution of MDEs by m(y, τ) at any micro-point (y, τ) ∈ εY× [0, ∆t], we observe that
the cancer cell population, located within an appropriately chosen distance γh > 0 from






c(x, t0 + τ) dy
λ(B(y, γh) ∩Ω(t0))
y ∈ εY ∩Ω(t0),
0 y /∈ εY \ (Ω(t0) + {z ∈ Y | ‖z‖2 < ρ}),
(12)
where 0 < ρ < γh is a small mollification range and B(y, γh) denotes the ‖ · ‖∞ ball of
radius γh centred at a micro-node y. Since the calculation of this micro-scale MDE source
(12) directly involves the macro-scale cancer cell population c(·, ·), we observe a naturally
arising MDE top-down link that connects the macro-scale to the MDE micro-scale. In fact,
such a source term (12) allows us to describe the spatio-temporal evolution of the MDEs’
micro-scale distribution m(·, ·) by [20]
∂m
∂τ
= Dm∆m + h(y, τ),







where Dm > 0 is the constant MDEs diffusion coefficient and n denotes the outward normal
vector. As it was shown in [20], we can use the solution of the MDEs micro-dynamics (13)
to acquire both the movement direction and magnitude of a tumour boundary point x∗εY
within the peritumoral area covered by the associated boundary micro-domain εY. This
ultimately causes a boundary movement, and as a consequence, we obtain a new evolved
tumour macro-domain Ω(t0 + ∆t), the link of which we refer to as the MDE bottom-up link.
For the illustration of the boundary movement, we refer the reader to Figure 1c and for
further details of the MDE micro dynamics, see Appendix C or [20,26–30].
3. Computational Results: Numerical Simulations in 3D
We start this section by briefly discussing the numerical method that we use to solve
the macro-scale dynamics (7), and for details on the numerical approach used for the two
micro-scale dynamics (fibres and MDE), we refer the reader to [29,30]. Here, we use the
method of lines’ approach to discretise the macro-scale tumour dynamics (7) first in space,
and then, for the resulting system of ODEs, we employ a non-local predictor–corrector
scheme [26]. In this context, we carry out the spatial discretisation on a uniform grid,
where both spatial operators (fully anisotropic diffusion and adhesion) are accurately
approximated in a convolution-driven fashion. First, we note that the fully anisotropic
diffusion term can be split into two parts:
















which enable us to use a combination of two appropriate distinct schemes for an accurate
approximation. While for the diffusive part in (14), we use the symmetric finite difference





Ac(x, t, u, θ f ) +∇ ·DT(x)
)]
), we use the standard first-order upwind finite difference
scheme which ensures positivity and helps avoiding spurious oscillations in the solution.
Finally, to approximate the adhesion integral Ac(x, t, u, θ f ), we consider an approach
similar to [29,30], and use Ns random points located within the sensing region B(0, R) and
sums of discrete-convolutions.
3.1. Initial Conditions
For the numerical simulations presented in this paper, we consider the tissue cube









and for the non-fibre ECM phase, the initial condition l(x, 0) was acquired by appropriately
scaling the T1 weighted image via a normalising constant. Current DTI scans do not
provide suitable resolution to determine the underlying micro-fibre distributions, and
so here we describe the initial micro-fibre distribution within a micro-domain δY(x) as
follows. When the macro-scale point x that corresponds to the micro-domain δY(x) is
located in the grey matter, then within δY(x), we randomly draw straight lines until the
ratio between the points that belong and the points that do not belong to the collection
of lines is approximately 35%: 65%. On the other hand, when the point x is located
within the white matter, we use a set of predefined lines with the same point ratio (35%:
65%), ultimately achieving a random orientation within the grey matter and an aligned
orientation within the white matter [101]. Finally, the grey matter’s fibre density is assumed
to be 1/DG times smaller than the density in the white matter [101]. A schematics of this
initial condition for the micro-fibres can be seen in Figure 2. Hence, we also incorporated
the information about the white and grey matter tracks provided by the T1 weighted image






Figure 2. Schematics of the initial condition of the micro-fibres (blue lines) within a micro-domain
δY(x) of orientation θ f (x, t) located in the (a) white matter and in the (b) grey matter.
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3.2. Numerical Simulations in 3D
Here, we present the 3D numerical solutions of the multi-scale model described above,
for the parameter values listed in Table A1 in Appendix A (any alteration from these values
will be stated accordingly). To display the advanced tumours at time 50∆t, we show four
panels for each simulation result. In the first three panels, we show the three classical
cross-section planes, i.e., the coronal plane (the head of the subject is viewed from behind),
the axial plane (the head of the subject is viewed from above) and the sagittal plane (the
head of the subject is viewed from the left). In the last panel of each simulation, we show
the 3D image of the brain with the embedded tumour alongside the 3D tumour in isolation.
The three figures shown below investigate tumour evolution when the initial tumour
starts in different regions of the brain. To present the simulations, we divide each result
into four panels: coronal, axial, sagittal and 3D view. Within each coronal, axial and sagittal
views, we show the tumour embedded within the brain on the left, the cancer cell density
on the top-right and the ECM density on the bottom-right. In the 3D view (the furthest
right panel in each result), we show the cross-section of the whole brain with the tumour
in the bottom-left corner and in the top-right corner, we show the isolated tumour.
In Figure 3, we present three distinct cases obtained by varying different parameters
that appear in the tumour diffusion tensor DT(x) defined in (3). In Figure 3a, we assume
that the tensor DT(x) depends on the white–grey matter and for this purpose we set r = 1
in (3) and a = 0 in (4); this results in isotropic tumour diffusion. In Figure 3b, we use
the DTI data (i.e., there is no a priori assumption about the preferential direction for cell
movement in white matter) and thus we set a = 1 in (4) (with r = 0.1, as in Table A1); this
results in an anisotropic diffusion that does not explicitly depend on the white–grey matter.
In Figure 3c, we use both DTI data and the white–grey matter dependency (i.e., r = 0.1 and
a = 0), with the baseline parameters from Table A1. Here, it is worth mentioning that even
though we do not use the T1 weighted image to obtain the functions w(x) and g(x) that
appear in DWG (such as DWG = 1 in Figure 3b, since a = 1) we still use the T1 weighted
image to initialise the micro-scale non-fibre initial density as well as the initial micro-scale
fibre distributions as described above.
In all these simulations shown in Figure 3, we place the small initial tumour in the
middle-right part of the brain, and we show the results of the three cases at time 50∆t
where we observe significant tumour morphology changes across the three cases. By
comparing Figure 3a,b and Figure 3b,c, we see that when we include the white–grey matter
dependency function DWG within the tumour diffusion tensor, it leads to a more advanced
tumour. On the other hand, comparing Figure 3a with Figure 3c shows that including the
DTI data, which creates an anisotropic tumour diffusion term, leads to a slight reduction in
tumour spread. Furthermore, in all three cases, we can notice that the advancing tumour
tends to mostly follow the white matter tracks and usually avoids the invasion of tissues
located in the grey matter. This invasion resulted in the degradation (and rearrangement)
of the ECM that we can see in the bottom-right of each panel (coronal, axial and sagittal)
which enabled the tumour to further expand into the surrounding tissues.
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Figure 3. 3D computer simulation results: (a) with only white-grey matter dependency (r = 1), (b) with only DTI data used
(DG = 1), (c) with both white-grey matter dependency and DTI data incorporated. To present the simulations, we divide
each result into four panels: coronal, axial, sagittal and 3D view. Within each coronal, axial and sagittal views, we show
the tumour embedded within the brain on the left, the cancer cell density on the top-right and the ECM density on the
bottom-right. In the 3D view (the furthest right panel in each result) we show the cross-section of the whole brain with the
tumour on the bottom-left corner and on the top-right corner we show the isolated tumour.
In Figure 4, we keep the same three cases as in Figure 3, i.e., Figure 4a only white-
grey matter dependency, Figure 4b only DTI data and Figure 4c both. However, here we
place the initial tumour in the front-right part of the brain and show the results of tumour
invasion at the final time 50∆t. Due to the initial position of the tumour, we can see a
tumour that is growing away from the skull towards the centre of the brain as well as
it is mainly following the white matter. This creates a highly heterogeneous elongated
tumour with many branching outgrowths. On the other hand, in Figure 4 we only see
slight differences between the three cases. This contradicts the results from Figure 3 and
suggests that both the DTI data and white-grey matter dependency may not always be
decisive factor in tumour morphology.
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Figure 4. 3D computer simulation results (a) with only white–grey matter dependency (r = 1); (b) with only DTI data used
(DG = 1); and (c) with both white–grey matter dependency and DTI data incorporated. To represent the simulation results,
we use the same format as in Figure 3.
Similarly to Figures 3 and 4, in Figure 5 we keep the same three cases (Figure 5a only
white–grey matter dependency Figure 5b only DTI data and Figure 5c both) while we place
the initial tumour mass in the middle of the brain and present the results at time 50∆t. As a
consequence of the initial location, we see a “butterfly”-shaped tumour that branched to
both the left and right side of the brain with some asymmetry. Furthermore, as in Figure 4,
we can see that all three cases are quite similar, and so the additional information provided
by both the DTI data and white–grey matter dependency seems to be unnecessary for this
initial condition. However, we must note that the initial conditions (fibre and non-fibre
ECM) still use the information provided by the T1 weighted image, and so here, we only
investigate the effect of changing the diffusion tensor.
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Figure 5. 3D computer simulation results: (a) with only white–grey matter dependency (r = 1); (b) with only DTI data used
(DG = 1); (c) with both white–grey matter dependency and DTI data incorporated. To represent the simulation results, we
use the same format as in Figure 3.
As we mentioned, we see significant differences between the three cases only in
Figure 3. This either indicates that the anisotropic diffusion tensor only provides valuable
information in certain cases or that the initial micro-fibre density differs from the one that
produced the DTI scan, (i.e., the actual distribution). Since we use an artificial micro-fibre
structure that does not depend on the DTI scan which also aids the movement of the cancer
cell population via the adhesion integral Ac(·, ·, ·, ·) defined in (5), it is possible that in this
specific case, the micro-scale fibre distribution introduced a significantly different travelling
direction than the DTI data, resulting in discrepancies between the simulations. However,
due to the resolution of current DTI scans, it is not possible to construct a unique fibre
distribution within a micro-domain δY(x). Hence, to genuinely capture the underlying
brain structures that we can use within a mathematical model, our results suggest that
DTI scans with their present resolution may not be sufficient, and one might need to
look into either obtaining better resolution DTI scans or combine this with the strength of
different technologies such as magnetic resonance elastography. Nonetheless, this exceeds
the current scope of this work and requires further investigation.
4. Discussion and Final Remarks
In this study, we further extended the 2D multi-scale moving-boundary framework
previously introduced in [20,26], by developing it into 3D and applying it to the study
of glioma invasion within the brain. Since experiments are limited within the brain, we
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focused on incorporating DTI and T1 weighted scans into our framework to provide
insights into the structure of the brain, the tumour, and the surrounding tissue.
The original framework developed in [20,26] modelled a generic tumour in a 2D
setting, and so to model gliomas within a 3D brain, we extended this modelling approach
by considering the structural information provided by both DTI and T1 weighted scans.
We used both DTI and T1 weighted scans to construct the tumour diffusion tensor DT(x)
defined in (3), which resulted in a fully anisotropic diffusion term. While the T1 weighted
image can give different diffusion rates based on whether the cancer cells are located in the
white or grey matter, the DTI data are used to incorporate the underlying brain structure
and to give higher diffusion rates along specific directions based on how the measured
water molecules behaved within the brain. The T1 weighted image, which provided the
white–grey matter densities, were also used in our initial conditions for both ECM phases.
Hence, the initial density of the non-fibre ECM phase was taken as a normalised version
of the T1 weighted image, and the initial condition of the micro-fibre distribution and
magnitude were also considered to be dependent on the white–grey matter structure.
Furthermore, as the available DTI scans lack the adequate resolution required to construct
more appropriate micro-fibre distributions, in this work, we considered a simple case
where we set the fibre distributions to be either random or oriented based on whether they
are positioned in the grey or white matter, respectively.
Therefore, compared to other previous 3D models such as those in [35–37], here we can
explicitly capture the underlying tissue structure changes via the micro-fibre rearrangement
process and trace how the boundary of the tumour changes over time. Moreover, the cancer
cells’ movement is not only influenced by the T1 weighted and DTI scans (through an
anisotropic diffusion term), but also biased by crucial non-local adhesions such as cell–cell
and cell–fibre ECM adhesion, the latter of which is naturally interconnected to the tissue
structural changes. Hence, our model presents a novel approach that can incorporate
several vital processes for tumour development and have not been available in other
previous models. This allowed us to produce exciting and valuable results/outcomes
which provide further insights into the overall tumour development process.
To this end, we used this new 3D model to explore the effects of the anisotropic
diffusion term for the cancer cell population. Our numerical simulations in Figure 3 show
that including an anisotropic diffusion term may lead to significant changes in the overall
tumour morphology. However, it seems that these changes depend on the position of the
tumour inside the brain, as Figures 4 and 5 do not exhibit changes consistent with the
ones observed between the three sub-panels of Figure 3. This may be the result of the
underlying brain structure and its microscopic fibre representation, which seems to take a
leading role in influencing cancer-invasion patterns through the underlying cell-adhesion
process (see Equation (5)), thus overshadowing the diffusion process. More precisely, the
simplified fibre representation might not be sufficient for Figure 3, where the initial tumour
was positioned in the right-middle part of the brain. However, this fibre representation
might be enough for Figure 4 (with the tumour positioned in the front-right of the brain)
and for Figure 5 (with the tumour positioned in the middle of the brain), where we did not
see significant morphological differences between the three sub-panels considered in each
of these figures.
To conclude this study, we mention that further investigation is needed to determine
whether these changes in tumour invasion patterns are caused by the lack of directional in-
formation on the fibre micro-scale level or an anisotropic diffusive cell motility is necessary
to better represent the invasion process. A feasible approach would also be to use a new
imaging technology called magnetic resonance elastography, but this is beyond the scope
of this current work. Nonetheless, these results are not only interesting and important from
a mathematical modelling point of view but from a medical one as well. For instance, we
showed how different model parameters change the evolution of the tumour boundary,
this being a vital and desired datum in any clinical/medical decision-making process. Such
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a model with tuned parameters (to specific patients) could help, for example, decide the
optimal amount of tissue to resect so that the chance of survival is maximised.
Finally, as our simulations are able to reproduce known tumour patterns of clinically seen
growth, future experiments will be refined by prospectively collected MRI data from glioma
patients and also incorporate the effects of their radiotherapy and chemotherapy treatments.
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Appendix A. Parameter Values
In Table A1, we summarise the parameter values that were used in the presented
numerical simulations.
Table A1. Parameter set used for the numerical simulations.
Variable Value Description Reference
Dc 1.25× 10−4 Diffusion coeff. for the cancer cell population [37]
DG 0.25 Grey matter regulator coefficient Estimated
r 0.1 Degree of randomised turning [37]
a 0 Model switching parameter Estimated
KFA 100 Cell’s sensitivity to the directional information [37]
Smax 0.5 Cell–cell adhesion coeff. [26]
Smin 0.01 Minimum level of cell–cell adhesion [29]
Scl 0.01 Cell–non-fibre adhesion coeff. [26]
ScF 0.3 Cell–fibre adhesion coeff. [19]
µ 0.25 Proliferation coeff. for cancer cell population [19]
βF 1.5 Degradation coeff. of the fibre ECM [30]
βl 3.0 Degradation coeff. of the non-fibre ECM [30]
β 0.8 Optimal tissue environment controller [20]
R 0.15 Sensing radius [26]
fmax 0.636 Maximum of micro-fibre density at any point [26]
∆x 0.03125 Macro-scale spatial step-size [20]
ε 0.0625 Size of a boundary micro-domain εY(x) [20]
δ 0.03125 Size of a fibre micro-domain δY(x) [26]
Ns 450 Number of random points used for the Estimated
approximation of the adhesion integral Ac
Appendix B. Further Details on the Micro-Fibre Rearrangement Process
In Section 2.2.1, we highlighted the fact that the rearrangement of micro-fibre dis-
tribution f (z, t) within each δY(x) is initiated by the macro-scale cell fluxes, resulting in
the redistribution of each micro-fibre pixel z to a new position z∗. To calculate this new
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position z∗, we used the so-called reallocation vector νδY(x)(z, t) which takes into account the
rearrangement vector r(δY(x), t), defined in (10), the degree of alignment between r(δY(x), t)
and the barycentral position vector xdir := z− x and also incorporates the level of fibres at
position z. Hence, following [26], we define it as
νδY(x)(z, t) :=
[
xdir(x) + r(δY(x), t)
]
· f (z, t)[ fmax − f (z, t)]
f ∗+ ‖ r(δY(x), t)− xdir(x) ‖2
· χ{ f (z,t)>0},
where fmax > 0 is the maximum level of fibres, f ∗ := f (x, t)/ fmax is the saturation level
and χ{ f (z,t)>0} is the characteristic function of the micro-fibres support. To move the
appropriate amount of fibres from position z to the new position z∗, given in (11), we
also monitor the available amount of free space at this target position z∗ via a movement
probability pmove that we define it as
pmove := max
(





Consequently, we transport a pmove · f (z, t) amount of fibres to the new position z∗
and the rest (1− pmove) · f (z, t) remains at the original position z.
Appendix C. Further Details on the MDE Micro-Scale
Following [20], we briefly detail here the way the MDE micro-dynamics (13) deter-
mines the macro-boundary of the progressed tumour domain Ω(t0 + ∆t). To that end, on
any arbitrary boundary micro-domain εY ∈ P(t0), we consider an appropriate dyadic
cubes decomposition {Dk}I , and we denote the barycentre of each Dk by yk. Then, a
subfamily of small dyadic cubes {Dk}J ∗ is sub-sampled by selecting only those dyadic
cubes that are the furthest away from the boundary point x∗εY while being located outside
of the tumour domain Ω(t0) and carrying an above-average mass of MDEs. This enables
us to define the associated direction ηεY and displacement magnitude ξεY of the movement,
which are given by
ηεY(x∗εY)





















Although a movement direction and a displacement magnitude can thus be deter-
mined for each boundary point ξεY, the actual relocation of ξεY only occurs if sufficient but
not complete ECM degradation will have occurred in the peritumoral region εY \Ω(t0). To








Then, the movement of a boundary point is only exercised when the adequate but
not complete degradation of the peritumoral ECM occurs, which is characterised by the
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situation when this transitional probability q(x∗εY) exceeds a certain tissue threshold ω(·, ·)
































where β ∈ (0, 1) controls the optimal level of ECM for cancer invasion and v(x, t) :=
l(x, t) + F(x, t).
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